• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

AGR2 表达与腔面型乳腺癌转移发生率的相关性。

Correlation of AGR2 expression with the incidence of metastasis in luminal breast cancer.

机构信息

Department of Surgery, Faculty of Medicine, Universitas Hasanuddin, Makassar, Indonesia.

出版信息

Breast Dis. 2021;40(S1):S103-S107. doi: 10.3233/BD-219015.

DOI:10.3233/BD-219015
PMID:34092584
Abstract

BACKGROUND

AGR2 expression is associated with luminal breast cancer. Overexpression of AGR2 is a predictor of poor prognosis. Several studies have found correlations between AGR2 in disseminated tumor cells (DTCs) in breast cancer patients.

OBJECTIVE

This study aims to determine the correlation between anterior Gradient2 (AGR2) expression with the incidence of distant metastases in luminal breast cancer.

METHODS

This study was an observational study using a cross-sectional method and was conducted at Wahidin Sudirohusodo Hospital and the network. ELISA methods examine AGR2 expression from blood serum of breast cancer patients. To compare the AGR2 expression in metastatic patients and the non-metastatic patient was tested with Mann Whitney test. The correlation of AGR2 expression and metastasis was tested with the Rank Spearman test.

RESULTS

The mean value of AGR2 antibody expression on ELISA in this study was 2.90 ± 1.82 ng/dl, and its cut-off point was 2.1 ng/dl. Based on this cut-off point value, 14 subjects (66.7%) had overexpression of AGR2 serum ELISA, and 7 subjects (33.3%) had not. The mean value AGR2 was significantly higher in metastatic than not metastatic, 3.77 versus 1.76 (p < 0.01). The Spearman rank test obtained a p-value for the 2 tail test of 0.003 (p < 0.05), which showed a significant correlation of both, while the correlation coefficient of 0.612 showed a strong positive correlation of AGR2 overexpression and metastasis.

CONCLUSIONS

AGR2 expression is correlated with metastasis in Luminal breast cancer.

摘要

背景

AGR2 表达与腔乳腺癌相关。AGR2 过表达是预后不良的预测因子。几项研究发现了乳腺癌患者播散性肿瘤细胞 (DTC) 中 AGR2 之间的相关性。

目的

本研究旨在确定前梯度 2 (AGR2) 表达与腔乳腺癌远处转移发生率之间的相关性。

方法

本研究为观察性研究,采用横断面方法,在万隆苏迪罗胡索多医院及其网络进行。ELISA 方法检测乳腺癌患者血清中 AGR2 的表达。采用 Mann-Whitney 检验比较转移性患者和非转移性患者的 AGR2 表达。采用秩和 Spearman 检验检验 AGR2 表达与转移的相关性。

结果

本研究 ELISA 检测 AGR2 抗体表达的平均值为 2.90 ± 1.82ng/dl,其截断值为 2.1ng/dl。基于该截断值,14 名受试者(66.7%)的血清 ELISA 中 AGR2 过表达,7 名受试者(33.3%)没有。转移性患者的 AGR2 平均值明显高于非转移性患者,分别为 3.77 与 1.76(p<0.01)。双侧 2 尾检验的 Spearman 秩检验得到 p 值为 0.003(p<0.05),表明两者之间存在显著相关性,而 0.612 的相关系数表明 AGR2 过表达与转移之间存在强烈的正相关。

结论

AGR2 表达与腔乳腺癌的转移相关。

相似文献

1
Correlation of AGR2 expression with the incidence of metastasis in luminal breast cancer.AGR2 表达与腔面型乳腺癌转移发生率的相关性。
Breast Dis. 2021;40(S1):S103-S107. doi: 10.3233/BD-219015.
2
LINC02273 drives breast cancer metastasis by epigenetically increasing AGR2 transcription.LINC02273 通过表观遗传增加 AGR2 转录来驱动乳腺癌转移。
Mol Cancer. 2019 Dec 19;18(1):187. doi: 10.1186/s12943-019-1115-y.
3
Anterior gradient protein 2 is a marker of tumor aggressiveness in breast cancer and favors chemotherapy‑induced senescence escape.前梯度蛋白 2 是乳腺癌侵袭性的标志物,并有利于化疗诱导的衰老逃逸。
Int J Oncol. 2022 Jan;60(1). doi: 10.3892/ijo.2021.5295. Epub 2021 Dec 16.
4
Urokinase type plasminogen activator receptor (uPAR) and human epidermal growth factor receptor 2 (HER2) expression in metastasis of breast cancer.尿激酶型纤溶酶原激活物受体(uPAR)和人类表皮生长因子受体 2(HER2)在乳腺癌转移中的表达。
Breast Dis. 2021;40(S1):S1-S7. doi: 10.3233/BD-219001.
5
The estrogen-regulated anterior gradient 2 (AGR2) protein in breast cancer: a potential drug target and biomarker.雌激素调节的乳腺癌前梯度2(AGR2)蛋白:一个潜在的药物靶点和生物标志物。
Breast Cancer Res. 2013 Apr 24;15(2):204. doi: 10.1186/bcr3408.
6
Basic helix-loop-helix transcription factor Twist1 is a novel regulator of anterior gradient protein 2 homolog (AGR2) in breast cancer.碱性螺旋-环-螺旋转录因子 Twist1 是乳腺癌中前梯度蛋白 2 同源物(AGR2)的新型调节因子。
Biochem Biophys Res Commun. 2019 Aug 13;516(1):149-156. doi: 10.1016/j.bbrc.2019.05.191. Epub 2019 Jun 12.
7
The metastasis-associated anterior gradient 2 protein is correlated with poor survival of breast cancer patients.转移相关的前梯度蛋白 2 与乳腺癌患者的不良预后相关。
Am J Pathol. 2009 Nov;175(5):1848-57. doi: 10.2353/ajpath.2009.090246. Epub 2009 Oct 15.
8
Anterior Gradient 2 is a Poor Outcome Indicator in Luminal Breast Cancer.前梯度2是管腔型乳腺癌预后不良的指标。
Ann Surg Oncol. 2015 Oct;22(11):3489-96. doi: 10.1245/s10434-015-4420-8. Epub 2015 Feb 7.
9
[Expression of a novel metastasis-inducing protein human anterior gradient-2 (AGR2) in breast cancer and its clinical and prognostic significance].[一种新型转移诱导蛋白人前梯度-2(AGR2)在乳腺癌中的表达及其临床和预后意义]
Zhonghua Bing Li Xue Za Zhi. 2008 Feb;37(2):109-13.
10
AGR2 diagnostic value in nasopharyngeal carcinoma prognosis.AGR2 在鼻咽癌预后中的诊断价值。
Clin Chim Acta. 2018 Sep;484:323-327. doi: 10.1016/j.cca.2017.12.023. Epub 2017 Dec 18.

引用本文的文献

1
Agr2 in cancer and beyond: unraveling its role during protein synthesis, ER stress, and as a predictive biomarker.Agr2在癌症及其他领域:揭示其在蛋白质合成、内质网应激过程中的作用以及作为预测性生物标志物的作用
Mol Cell Biochem. 2025 Jun 5. doi: 10.1007/s11010-025-05318-8.
2
Quercetin represses cholesterol metabolism and mitigates resistance to cisplatin in oral squamous cell carcinoma by regulating AGR2/AKT/SREBP2 axis.槲皮素通过调节AGR2/AKT/SREBP2轴抑制口腔鳞状细胞癌中的胆固醇代谢并减轻对顺铂的耐药性。
Heliyon. 2024 Sep 11;10(18):e37518. doi: 10.1016/j.heliyon.2024.e37518. eCollection 2024 Sep 30.
3
AGR2: a secreted protein worthy of attention in diagnosis and treatment of breast cancer.
AGR2:一种在乳腺癌诊断和治疗中值得关注的分泌蛋白。
Front Oncol. 2023 May 1;13:1195885. doi: 10.3389/fonc.2023.1195885. eCollection 2023.
4
Microenvironment components and spatially resolved single-cell transcriptome atlas of breast cancer metastatic axillary lymph nodes.乳腺癌转移性腋窝淋巴结的微环境成分和空间分辨单细胞转录组图谱。
Acta Biochim Biophys Sin (Shanghai). 2022 Sep 25;54(9):1336-1348. doi: 10.3724/abbs.2022131.
5
CDKN2A-mediated molecular subtypes characterize the hallmarks of tumor microenvironment and guide precision medicine in triple-negative breast cancer.CDKN2A 介导的分子亚型可作为肿瘤微环境的特征,并指导三阴性乳腺癌的精准医学。
Front Immunol. 2022 Aug 16;13:970950. doi: 10.3389/fimmu.2022.970950. eCollection 2022.
6
DEAD-Box RNA Helicases DDX3X and DDX5 as Oncogenes or Oncosuppressors: A Network Perspective.DEAD盒RNA解旋酶DDX3X和DDX5作为癌基因或抑癌基因:网络视角
Cancers (Basel). 2022 Aug 6;14(15):3820. doi: 10.3390/cancers14153820.